Edition:
United States

Bioporto A/S (BIOPOR.CO)

BIOPOR.CO on Copenhagen Stock Exchange

2.68DKK
24 May 2017
Change (% chg)

kr.-0.01 (-0.37%)
Prev Close
kr.2.69
Open
kr.2.65
Day's High
kr.2.75
Day's Low
kr.2.65
Volume
339,269
Avg. Vol
368,110
52-wk High
kr.4.62
52-wk Low
kr.1.40

BIOPOR.CO

Chart for BIOPOR.CO

About

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay... (more)
No analyst recommendations are available for BIOPOR.CO.

Overall

Beta: 0.62
Market Cap(Mil.): kr.381.88
Shares Outstanding(Mil.): 142.49
Dividend: --
Yield (%): --

Financials

  BIOPOR.CO Industry Sector
P/E (TTM): -- 14.27 17.41
EPS (TTM): -0.17 -- --
ROI: -50.64 -7.17 -5.42
ROE: -51.37 -6.63 -4.68

BRIEF-Bioporto Q1 EBIT loss widens to DKK 9.3 million

* Q1 EBIT LOSS DKK 9.3 MILLION VERSUS LOSS DKK 5.4 MILLION YEAR AGO

May 04 2017

BRIEF-Bioporto FY EBIT loss widens to DKK 25.0 million

* FY revenue 20.7 million Danish crowns ($3 million) versus 20.4 million crowns year ago

Mar 15 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.